建立和验证第四阶段非小细胞肺癌的生存预测模型:现实世界的研究
Keao Zheng1, Junyan Zhang2, Tingting Xu1
1School of Pharmacy, Shanxi Medical University, Taiyuan, China.
Frontiers in immunology
|March 21, 2025
概括
这项研究开发了先进非小细胞肺癌 (NSCLC) 存活率的预测模型. 研究结果表明,结合化疗和免疫治疗,与单独使用化疗相比,改善整体存活率.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 生物统计学 生物统计学
背景情况:
- 晚期非小细胞肺癌 (NSCLC) 在患者管理中构成了重大挑战.
- 准确预测生存率对于定制治疗策略至关重要.
研究的目的:
- 开发和验证先进NSCLC患者3年生存预测模型.
- 整合基本的患者信息和临床数据,以提高预后准确度.
主要方法:
- 使用了462名晚期NSCLC患者的队列,分为培训和验证组.
- 考克斯回归分析确定了3年生存时间的独立因素.
- 模型性能使用C指数,校准曲线,ROC和DCA进行评估.
- 倾向性得分匹配用于对化疗方案进行比较的子组分析.
主要成果:
- 创建了一个预后模型和名图,将患者分为高风险和低风险组.
- 高风险组在两个队伍中均表现出明显较差的整体存活率 (OS).
- 亚组分析证实,联合化疗和免疫疗法改善了晚期NSCLC患者的生存状况.
结论:
- 成功开发了一种经过验证的临床预测模型,用于高级NSCLC患者的3年生存期.
- 化学疗法与免疫疗法相结合,在先进的NSCLC中显示出比单独的化学疗法更高的疗效.
相关概念视频
Cancer Survival Analysis
315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Kaplan-Meier Approach
71
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
71
Comparing the Survival Analysis of Two or More Groups
110
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
110
Actuarial Approach
50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Assumptions of Survival Analysis
77
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
77


